Photo-optical methods can lead to clinically relevant overestimation of fibrinogen concentration in plasma diluted with hydroxyethyl starch

Clinical and Applied Thrombosis/Hemostasis

Volumn 16, Issue 4, 2010, Pages 461-471

  Adam, Susanne ^a   Karger, Ralf ^a   Kretschmer, Volker ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

fibrinogen concentration; fibrinogen measurement; hydroxyethyl starch; major blood loss; massive transfusion; volume replacement

Indexed keywords

FIBRINOGEN; GELATIN; HETASTARCH; PHOSPHATE BUFFERED SALINE;

ARTICLE; COLLOID; FIBRINOGEN BLOOD LEVEL; HEMODILUTION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTHROMBIN TIME;

BLOOD CHEMICAL ANALYSIS; COLLOIDS; FIBRINOGEN; HEMOSTASIS; HETASTARCH; HUMANS; OPTICS AND PHOTONICS; PHOTOCHEMISTRY; PLASMA SUBSTITUTES;

EID: 77954907984     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029609342090     Document Type: Article

References (22)

1. Mittermayr M., Streif W., Haas T., et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg. 2007 ; 105 (4). 905-917.
2. Heindl B., Delorenzo C., Spannagl M. High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion [in German]. Anaesthesist. 2005 ; 54 (8). 787-790.
3. Fenger-Eriksen C., Anker-Moller E., Heslop J., Ingerslev J., Sørensen B. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth. 2005 ; 94 (3). 324-329.
4. Kretschmer V., Karger R., Weippert-Kretschmer M. Emergency and massive transfusion. In: Kretschmer V, Blauhut B, eds. Blood, Blood Products and Blood Saving Techniques. London: Bailliére Tindall ; 1997: 261-276. (Pubitemid 27379776)
5. Stainsby D., MacLennan S., Thomas D., Isaac J., Hamilton PJ, and the British Committee for Standards in Haematology. Guidelines for the management of massive blood loss. Br J Haematol. 2006 ; 135 (5). 634-641.
6. Hardy J-F., de Moerloose P., Samama CM, and the Members of the Groupe dIntérêt en Hémostase Périopératoire. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth. 2006 ; 53 (6 suppl). S40 - S58.
7. Fries D., Innerhofer P., Klingler A., et al. The effect of the combined administration of colloids and lactated Ringers solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg. 2002 ; 94 (5). 1280-1287.
8. Innerhofer P., Fries D., Margreiter J., et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg. 2002 ; 95 (4). 858-865.
9. Nielsen VG, Levy JH Fibrinogen and bleeding: old molecule-new ideas. Anesth Analg. 2007 ; 105 (4). 902-903.
10. Haisch G., Boldt J., Krebs C., Kumle B., Suttner S., Schulz A. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/04) on coagulation in patients undergoing major abdominal surgery. Anesth Analg. 2001 ; 92 (3). 565-571.
11. Haisch G., Boldt J., Krebs C., Suttner S., Lehmann A., Isgro F. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth. 2001 ; 15 (3). 316-321.
12. de Jonge E., Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med. 2001 ; 29 (6). 1261-1267.
13. Van der Linden PJ, Ickx BE The effects of colloid solutions on hemostasis. Can J Anaesth. 2006 ; 53 (6 suppl). S30 - S39.
14. Hiippala ST Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis. 1995 ; 6 (8). 743-746.
15. Strauss RG, Pennell BJ, Stump DC A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion. 2002 ; 42 (1). 27-36.
16. Jones SB, Whitten CW, Despotis GJ, Monk TG The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. Anesth Analg. 2003 ; 96 (2). 363-368.
17. Ruttmann TG, James MF, Aronson I. In vivo investigation into the effects of hemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. Br J Anaesth. 1998 ; 80 (5). 612-616.
18. Bland JM, Altman DG Measuring agreement in method comparison studies. Stat Methods Med Res. 1999 ; 8 (2). 135-160.
19. Rumley A., Woodward M., Hoffmeister A., Koenig W., Lowe GD Comparison of plasma fibrinogen by Clauss, prothrombin time-derived, and immunonephelometric assays in a general population: implications for risk stratification by thirds of fibrinogen. Blood Coagul Fibrinolysis. 2003 ; 14 (2). 197-201.
20. Petroianu GA, Maleck WH, Koetter KP, Liu J., Schmitt A. Effect of in vitro hemodilution with hydroxyethyl starch and dextran on the activity of plasma clotting factors. Crit Care Med. 2003 ; 31 (1). 250-254.
21. De Lorenzo C., Calatzis A., Welsch U., Heindl B. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg. 2006 ; 102 (4). 1194-1200.
22. Mackie IJ, Kitchen S., Machin SJ, Lowe GD for the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on fibrinogen assays. Br J Haematol. 2003 ; 121 (3). 396-404.